Latest News on Cloud, Data Center, and Web Hosting
Latest News on Cloud, Data Center, and Web Hosting
Website Hosting ReviewSAN JOSE, Calif.–(BUSINESS WIRE)–Calix, Inc. (NYSE: CALX) today announced that Calix management will participate in virtual investor meetings at the Barrington Research 2021 Virtual Spring Investment Conference on Thursday, May…
Read moreWebsite Hosting ReviewWHEATON, Ill.–(BUSINESS WIRE)–First Trust Energy Infrastructure Fund (the “Fund”) (NYSE: FIF) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.0625 per share payable on…
Read moreWebsite Hosting ReviewATLANTA–(BUSINESS WIRE)–Americold Realty Trust (NYSE: COLD) (the “Company” or “Americold”), the world’s largest publicly traded REIT focused on the ownership, operation, acquisition, and development of temperature-controlled warehouses, today announced that…
Read moreWebsite Hosting ReviewStudy leveraging the IBM® MarketScan® claims database examined healthcare resource utilization including total healthcare costs and bleeding costs in patients initiating P2Y12 inhibitors, FXa inhibitors or dabigatran Analyses revealed that…
Read moreWebsite Hosting ReviewAppoints Michelle J. Holthaus as a director effective immediately SANTA ROSA, Calif.–(BUSINESS WIRE)–$KEYS #BoardofDirectors–Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to…
Read moreWebsite Hosting ReviewSCHAUMBURG, Ill.–(BUSINESS WIRE)–Network Data Systems (NDS) received their 3-year recertification of ISO/IEC 27001:2013 and also earned ISO/IEC 27701:2019 certification. NDS has aggressively pursued the industry’s most stringent security requirements and…
Read moreWebsite Hosting ReviewMEMPHIS, Tenn.–(BUSINESS WIRE)–Frontdoor, Inc. (NASDAQ: FTDR), the nation’s leading provider of home service plans, today announced it is attending J.P. Morgan’s 49th Annual Global Technology, Media and Communications Conference, and…
Read moreWebsite Hosting Review– Study Achieved Primary Endpoint of mPFS in Patients Treated with Ficlatuzumab/Cetuximab (ERBITUX®) Combination – – 38% ORR, Including 13% CRs and 25% PRs, and Median PFS of 4.1 months…
Read moreWebsite Hosting Review– Patients Treated with Tivozanib in TIVO-3 Study Demonstrated Over 20 Months Median DOR; OS Relative to Sorafenib Continues to Improve with Longer Follow-up – – Analysis of TEAEs in…
Read moreWebsite Hosting ReviewDragonfly, Braintrace’s Proprietary Network Detection and Response (NDR) Application, Is Recognized for Its Early Malware Detection Beyond Industry Standards to Analyze Encrypted Traffic on Networks and in the Cloud. SALT…
Read more
%20Virtual%202021%20Conference){kind=link}
%20in%20Relapsed%20or%20Refractory%20Renal%20Cell%20Carcinoma){kind=link}
